Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Sebastien Hulot

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Circulation Research|February 23, 2013
Myocardial delivery of stromal cell-derived factor 1 in patients with ischemic heart disease: safe and promisingRoger J Hajjar, Jean-Sebastien Hulot
Journal of the American College of Cardiology|August 2, 2014
Modeling CVD in human pluripotent cells by genome editingRoger J Hajjar, Jean-Sebastien Hulot
European Heart Journal|February 29, 2016
Gene therapy for the treatment of heart failure: promise postponedJean-Sebastien Hulot, Kiyotake Ishikawa, Roger J Hajjar
Frontiers in Physiology|December 26, 2022
Editorial: Heart failure with preserved ejection fraction: Basic, translational, and clinical researchFabien Brette, Pierre Dos Santos, Jean-Sebastien Hulot
Clinical Pharmacology and Therapeutics|April 3, 2004
Nelfinavir and felodipine: a cytochrome P450 3A4-mediated drug interactionHassane Izzedine, Vincent Launay-Vacher, Gilbert Deray, et al.
Fundamental & Clinical Pharmacology|September 9, 2014
Pharmacology and mechanisms of action of new oral anticoagulantsJoe-Elie Salem, Pierre Sabouret, Christian Funck-Brentano, et al.
Annals of Internal Medicine|August 18, 2004
Beta-blocker-induced quadriparesisHassane Izzedine, Vincent Launay-Vacher, Jean Sebastien Hulot, et al.
Frontiers in Bioscience (Scholar Edition)|January 2, 2013
STIM1 and Orai in cardiac hypertrophy and vascular proliferative diseasesAnne-Marie Lompre, Ludovic Benard, Ypuakim Saliba, et al.
Current Pharmaceutical Design|June 26, 2012
Pharmacogenetics of clopidogrelStephen A O'Connor, Jean-Sebastien Hulot, Johanne Silvain, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 1, 2014
Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography-tandem mass spectrometryMarie Korostelev, Kevin Bihan, Lison Ferreol, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Circulation Research|February 23, 2013
Myocardial delivery of stromal cell-derived factor 1 in patients with ischemic heart disease: safe and promisingRoger J Hajjar, Jean-Sebastien Hulot
Journal of the American College of Cardiology|August 2, 2014
Modeling CVD in human pluripotent cells by genome editingRoger J Hajjar, Jean-Sebastien Hulot
European Heart Journal|February 29, 2016
Gene therapy for the treatment of heart failure: promise postponedJean-Sebastien Hulot, Kiyotake Ishikawa, Roger J Hajjar
Frontiers in Physiology|December 26, 2022
Editorial: Heart failure with preserved ejection fraction: Basic, translational, and clinical researchFabien Brette, Pierre Dos Santos, Jean-Sebastien Hulot
Clinical Pharmacology and Therapeutics|April 3, 2004
Nelfinavir and felodipine: a cytochrome P450 3A4-mediated drug interactionHassane Izzedine, Vincent Launay-Vacher, Gilbert Deray, et al.
Fundamental & Clinical Pharmacology|September 9, 2014
Pharmacology and mechanisms of action of new oral anticoagulantsJoe-Elie Salem, Pierre Sabouret, Christian Funck-Brentano, et al.
Annals of Internal Medicine|August 18, 2004
Beta-blocker-induced quadriparesisHassane Izzedine, Vincent Launay-Vacher, Jean Sebastien Hulot, et al.
Frontiers in Bioscience (Scholar Edition)|January 2, 2013
STIM1 and Orai in cardiac hypertrophy and vascular proliferative diseasesAnne-Marie Lompre, Ludovic Benard, Ypuakim Saliba, et al.
Current Pharmaceutical Design|June 26, 2012
Pharmacogenetics of clopidogrelStephen A O'Connor, Jean-Sebastien Hulot, Johanne Silvain, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 1, 2014
Simultaneous determination of rivaroxaban and dabigatran levels in human plasma by high-performance liquid chromatography-tandem mass spectrometryMarie Korostelev, Kevin Bihan, Lison Ferreol, et al.
Pageof 5